The suit by GenBioPro, the generic maker of mifepristone, is the latest strand in the intense legal battle over abortion pills.

The judges blocked the drug from being sent to patients through the mail and rolled back other steps the government had taken to ease access.

One invalidated the F.D.A.’s approval of the abortion pill mifepristone. The other ordered the F.D.A. to do nothing to restrict the pill’s availability.

The Texas judge’s ruling was quickly contradicted by another federal judge in Washington State who ordered the F.D.A. to keep mifepristone available.

Wyoming’s Constitution guarantees a right to make individual health care decisions. The new ban attempts to circumvent that right by declaring that abortion is not...

The first hearing in a lawsuit that seeks to overturn F.D.A. approval of the pills takes place Wednesday morning in Texas.

The decision applies to 21 states whose attorneys general threatened Walgreens and other pharmacies with legal action if they dispensed the pill there.

The suit argues that rules applying to mifepristone unnecessarily limit patients’ access to medication abortion.

The results of an innovative study suggest electrical stimulation of the spinal cord could eventually help some of the many people disabled by strokes.

The case, brought by GenBioPro, a company that makes one of two abortion drugs, argues that it is unconstitutional for a state to bar access...